凝集素样氧化低密度脂蛋白受体1(LOX1)多克隆抗体
Polyclonal Antibody to Lectin Like Oxidized Low Density Lipoprotein Receptor 1 (LOX1)
OLR1; CLEC8A; SCARE1; Oxidized low-density lipoprotein receptor 1; C-type lectin domain family 8 member A; Lectin-like oxidized LDL receptor 1; Lectin-type oxidized LDL receptor 1
- 编号PAB859Ra01
 - 物种Rattus norvegicus (Rat,大鼠)相同的名称,不同的物种。
 - 来源多抗制备
 - 宿主兔
 - 效价-
 - Ig类型IgG
 - 纯化方式抗原特异性亲和纯化
 - 标记物无标记物
 - 免疫原RPB859Ra01-凝集素样氧化低密度脂蛋白受体1(LOX1)重组蛋白
 - 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
 - 性状液体
 - 浓度0.5mg/mL
 - 且适物种Mus musculus (Mouse,小鼠)
 - 应用WB; IHC
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载英文说明书 中文说明书
 - 规格20µl100µl200µl1ml10ml
 - 价格¥ 652¥ 1520¥ 2172¥ 5430¥ 21720
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
特异性
该抗体是针对LOX1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别LOX1。
用法
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种:Rattus norvegicus (Rat,大鼠) | 应用(仅供研究使用,不用于临床诊断!) | 
| RPB859Ra01 | 凝集素样氧化低密度脂蛋白受体1(LOX1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB859Ra01 | 凝集素样氧化低密度脂蛋白受体1(LOX1)多克隆抗体 | WB; IHC | 
| MAB859Ra21 | 凝集素样氧化低密度脂蛋白受体1(LOX1)单克隆抗体 | WB; IHC; ICC; IP. | 
| SEB859Ra | 凝集素样氧化低密度脂蛋白受体1(LOX1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB859Ra | 凝集素样氧化低密度脂蛋白受体1(LOX1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
参考文献
| 杂志 | 参考文献 | 
| Clinical Cardiology | Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Associated With Angiographic Coronary Lesion Complexity in Patients With Coronary Artery Diseas[PubMed: 21400544] | 
| Coronary Artery Disease | Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease[LWW: 06000] | 
| Clinical Biochemistry | Soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in synovial fluid are correlated with disease severity of knee osteoarthritis[ScienceDirect: S0009912011004905] | 
| Mediators of Inflammation | Pregnancy Followed by Delivery May Affect Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels in Women of Reproductive Age[PubMed: 22619487] | 
| Dicle Medical Journal | Lectin-like oxidized low density lipoprotein receptor 1(LOX-1) levels and endothelial dysfunction in patients with primary essential hyperhidrosis/Primer esansiyel hiperhidroz hastalarinda lektin benzeri okside düsük dansiteli lipoprotein reseptor 1(LOX-1) düzeyleri ve endotel disfonksiyonu[Readperiodicals: Source] | 
| Journal of Clinical Laboratory Analysis | Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome[Pubmed:24798146] | 
| Journal of Human Hypertension | Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1[Pubmed:25007999] | 
| Gynecologic and Obstetric Investigation | Inhibition of Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Protects against Plasma/Hypoxia-Mediated Trophoblast Dysfunction Associated with Preeclampsia[Pubmed:25633310] | 
| World J Gastroenterol | Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease[PubMed: 26185381] | 
| Genetic Testing and Molecular Biomarkers | Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep Apnea[PubMed: 25825846] | 
| Neurotoxicology. | 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells.[pubmed:28167099] | 
| Journal of the American Heart Association | Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack[Pubmed:29330254] | 
| Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse …[] | |
| Disease Markers | Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous …[Pubmed: 31772687] | 
| Reproductive Biology | Polycystic ovary syndrome and endothelial dysfunction: A potential role for soluble lectin-like oxidized low density lipoprotein receptor-1[Pubmed: 32409108] | 
| Int J Cancer | The oxidized‐LDL/LOX‐1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells[Pubmed:35608341] | 







